{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:42:27Z","timestamp":1764996147136},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,7,15]]},"DOI":"10.2169\/internalmedicine.0568-17","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T22:26:47Z","timestamp":1520548007000},"page":"2051-2055","source":"Crossref","is-referenced-by-count":5,"title":["Successful Cord Blood Stem Cell Transplantation for Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated with Cerebral Infiltration"],"prefix":"10.2169","volume":"57","author":[{"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Himuro","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Katsushima","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Nasu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koya","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Inokura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ishizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 155: 483-492, 1999.","DOI":"10.1016\/S0002-9440(10)65144-9"},{"key":"2","unstructured":"2. Swerdlow SH, Jaffe ES; International Agency for Research on Cancer. World Health Organization. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, 2008: 439."},{"key":"3","unstructured":"3. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency of Research on Cancer, Lyon, 2017."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nofal A, Abdel-Mawla MY, Assaf M, Salah E. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation. J Am Acad Dermatol 67: 748-759, 2012.","DOI":"10.1016\/j.jaad.2011.07.043"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Robson A, Assaf C, Bagot M, et al. Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology 67: 425-441, 2015.","DOI":"10.1111\/his.12371"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic\/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 97: 610-627, 2003.","DOI":"10.1002\/cncr.11107"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Liu V, Cutler CS, Young AZ. Case records of the Massachusetts General Hospital. Case 38-2007. A 44-year-old woman with generalized, painful, ulcerated skin lesions. N Engl J of Med 357: 2496-2505, 2007.","DOI":"10.1056\/NEJMcpc0706687"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wehkamp U, Glaeser D, Oschlies I, Hilgendorf I, Klapper W, Weichenthal M. Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma. Br J Dermatol 173: 869-871, 2015.","DOI":"10.1111\/bjd.13792"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kikuchi Y, Kashii Y, Gunji Y, et al. Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. Pediatr Int 53: 393-396, 2011.","DOI":"10.1111\/j.1442-200X.2011.03369.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kato K, Oh Y, Takita J, et al. Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma. Int J Hematol 103: 196-201, 2016.","DOI":"10.1007\/s12185-015-1895-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang Y, Li T, Tu P, Wu LS, Zhu XJ. Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma clinically simulating pyoderma gangrenosum. Clin Exp Dermatol 34: e261-e262, 2009.","DOI":"10.1111\/j.1365-2230.2008.03172.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/14\/57_0568-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T05:10:29Z","timestamp":1532149829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/14\/57_0568-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,15]]},"references-count":11,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0568-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,15]]}}}